Investing in the bright future of advanced therapies
We are supported by top-tier healthcare and technology investors who share our vision of becoming a global leader in advanced therapies.
Spain as the European leader in cell therapy
Ideeea Therapeutics is part of the Spanish biotechnology ecosystem, which is becoming a Europen leader. The Spanish Agency for Medicines and Medical Devices (AEMPS) has authorized 930 studies in 2024, becoming the most European regulatory agency with most clinical trials approved. Regarding advanced therapy medicines, Spain is also a leader in Europe with a total of 52 trials authorized in 2024, with a promising future ahead. (Source: ASEBIO)
Nº
European regulatory agency in clinical trial approvals
Studies approved by AEMPS in 2024
ATMP trials approved in 2024
Discover relevant data about our key markets below
Institutions
External advisors
CDMO
Subscribe to our newsletter and enlighten your inbox with our latest news!
Bibliography
- Hamilton JB. Patterned loss of hair in man; types and incidence. Ann N Y Acad Sci. Mar 1951;53(3):708-28. doi:10.1111/j.1749-6632.1951.tb31971.x
- Yip L, Zaloumis S, Irwin D, Severi G, Hopper J, Giles G, Harrap S, Sinclair R, Ellis J. Gene-wide association study between the aromatase gene (CYP19A1) and female pattern hair loss. Br J Dermatol. Aug 2009;161(2):289-94. doi:10.1111/j.1365-2133.2009.09186.x
- Severi G, Sinclair R, Hopper JL, English DR, McCredie MR, Boyle P, Giles GG. Androgenetic alopecia in men aged 40-69 years: prevalence and risk factors. Br J Dermatol. Dec 2003;149(6):1207-13. doi:10.1111/j.1365-2133.2003.05565.x
- Norwood OT. Male pattern baldness: classification and incidence. South Med J. Nov 1975;68(11):1359-65. doi:10.1097/00007611-197511000-00009
- Salman KE, Altunay IK, Kucukunal NA, Cerman AA. Frequency, severity and related factors of androgenetic alopecia in dermatology outpatient clinic: hospital-based cross-sectional study in Turkey. An Bras Dermatol. Jan-Feb 2017;92(1):35-40. doi:10.1590/abd1806-4841.20175241
- Wang TL, Zhou C, Shen YW, Wang XY, Ding XL, Tian S, Liu Y, Peng GH, Xue SQ, Zhou JE, Wang RL, Meng XM, Pei GD, Bai YH, Liu Q, Li H, Zhang JZ. Prevalence of androgenetic alopecia in China: a community-based study in six cities. Br J Dermatol. Apr 2010;162(4):843-7. doi:10.1111/j.1365-2133.2010.09640.x
- He F, Shen M, Zhao Z, Liu Y, Zhang S, Tang Y, Xie H, Chen X, Li J. Epidemiology and disease burden of androgenetic alopecia in college freshmen in China: A population-based study. PLoS One. 2022;17(2):e0263912. doi:10.1371/journal.pone.0263912
- Bas Y, Seckin HY, Kalkan G, Takci Z, Citil R, Önder Y, Sahin S, Demir AK. Prevalence and types of androgenetic alopecia in north Anatolian population: A community-based study. J Pak Med Assoc. Aug 2015;65(8):806-9.
- Grand View Research. Alopecia Market Analysis. [Accessed February 10, 2025]. Available from: https://www.grandviewresearch.com/industry-analysis/alopecia-market
- Grand View Research. Stem Cell Therapy Market Analysis. [Accessed February 10, 2025]. Available from: https://www.grandviewresearch.com/industry-analysis/stem-cell-therapy-market-report